Eupatilin inhibits the proliferation of human esophageal cancer TE1 cells by targeting the Akt‑GSK3β and MAPK/ERK signaling cascades.
Wang X, Zhu Y, Zhu L, Chen X, Xu Y, Zhao Y, Shao Y, Li F, Jiang Y, Lu J, Huang Y, Chang X, Zhang J, Li X, Liu K, Zhao M, Dong Z, Zhao J.
Wang X, et al. Among authors: huang y.
Oncol Rep. 2018 Jun;39(6):2942-2950. doi: 10.3892/or.2018.6390. Epub 2018 Apr 23.
Oncol Rep. 2018.
PMID: 29693162